Pharmacology for Nurses · Lipid-Lowering Drugs
Bile Acid Sequestrants, Fibrates, and Niacin
On this page 9 sections
In 30 seconds
Before statins dominated lipid therapy, three older classes carried the load, and they remain useful — often as add-ons or when statins are not appropriate. Bile acid sequestrants grab bile acids in the intestine so the liver must make new ones from cholesterol, indirectly lowering LDL. Fibrates speed up the body's triglyceride-burning machinery, the classic choice for very high triglycerides. Niacin (nicotinic acid, a form of vitamin B3) reduces the liver's output of triglyceride-rich particles and raises HDL more than other agents. Each class has a distinct mechanism, a distinct "signature" effect on the lipid panel, and distinct teaching points. None should be initiated, dosed, or combined without reference to current guidelines and the prescriber's orders.
Why this matters
Lipid problems are not one disease. Some people have LDL-dominant patterns, some triglyceride-dominant, some both; the right drug depends on which fraction is the problem and on overall risk. These three classes give clinicians tools for patterns statins alone do not fully address. For nurses, they bring classic teaching and safety moments: drug-absorption timing with sequestrants, the statin–Fibrate PPARα agonist drug class (e.g., gemfibrozil, fenofibrate) Full entry → muscle-risk interaction, and the Niacin flush Warmth, redness, itching from prostaglandin-mediated vasodilation Full entry → that frightens patients who were not warned. Understanding the mechanism behind each side effect makes the teaching stick.
The college version
Core Concepts
Bile acid sequestrants: interrupting the recycling loop
The liver makes bile acids from cholesterol and secretes them into the intestine to digest fat; most are then reabsorbed in the ileum and returned — the Enterohepatic circulation Recycling loop returning most bile acids from intestine to liver Full entry →. Bile acid sequestrants (cholestyramine, colestipol, colesevelam) are large, positively charged, non-absorbed resins that bind bile acids in the gut and carry them out in stool. The liver responds by converting more cholesterol into new bile acids — and, like the statin story, up-regulating LDL receptors. Net effects: LDL falls (moderately) and triglycerides may rise, so these drugs are used cautiously when triglycerides are elevated. Signature issues are gastrointestinal (constipation, bloating) and — importantly for nursing — binding of other drugs and Fat-soluble vitamins Vitamins A, D, E, K absorbed with dietary fat Full entry →, which is why other medications are separated by a time interval.
Fibrates: turning up triglyceride clearance
Fibrates (gemfibrozil, fenofibrate) activate PPARα Nuclear receptor activating genes for fat-burning proteins like lipoprotein lipase Full entry →, a nuclear receptor that switches on genes for Lipoprotein lipase Enzyme releasing fatty acids from triglyceride-rich particles Full entry → and related proteins. More lipoprotein lipase means faster unloading of triglycerides from VLDL and chylomicrons, so triglycerides fall substantially and HDL rises; LDL effects are variable. Fibrates are the workhorse class for very high triglycerides — the kind of elevation carrying a risk of acute pancreatitis. The major safety concern is Myopathy Muscle damage with elevated creatine kinase Full entry →, especially combined with a statin; interaction profiles differ between gemfibrozil and fenofibrate, so any combination is a prescriber decision. Fibrates can also promote gallstones; monitoring is ordered by the clinician.
Niacin: the HDL raiser with the famous flush
Niacin (nicotinic acid, vitamin B3) works in the liver to reduce secretion of triglyceride-rich VLDL and slow HDL breakdown, giving it the largest HDL-raising effect among lipid drugs; it lowers triglycerides and LDL modestly. At lipid doses it inhibits the liver enzyme DGAT2 Liver enzyme that assembles triglycerides Full entry → (reducing triglyceride assembly). The teaching point everyone remembers is flushing — warmth, redness, itching, especially of the face and trunk — caused by prostaglandin-mediated vasodilation. Flushing is often reduced by taking the drug with food and avoiding alcohol and hot beverages around the dose — verify against the manufacturer's information. Other concerns: hyperglycemia, Hyperuricemia Elevated uric acid in the blood Full entry → (can aggravate gout), and hepatotoxicity (particularly some sustained-release forms). Because of these effects, niacin's modern role is limited and individualized.
Choosing by lipid phenotype
A useful frame: if the problem is LDL, the natural targets are receptor up-regulators (statins, PCSK9 inhibitors) and intestinal strategies (sequestrants, absorption inhibitors). If the problem is triglycerides, the targets are triglyceride-metabolism tools (fibrates; niacin historically). If the problem is low HDL, no drug is a clean fix — lifestyle (activity, weight, stopping tobacco) is the mainstay.
Nursing considerations across the three classes
- Sequestrants: teach powder/tablet use with liquid and food per instructions; separate other medications by the recommended interval; watch for constipation.
- Fibrates: reinforce reporting muscle pain or weakness, especially in combination therapy; regular labs (lipids, liver, kidney) are part of the plan.
- Niacin: warn about flushing before it happens so it is not mistaken for an allergic reaction; review glucose and uric acid monitoring if ordered.
- Across all three: timing and separation rules come from the manufacturer and prescriber — verify, don't guess; lifestyle measures continue.
How It Works / Step-by-Step Process
Follow a sequestrant through one day:
- Dose taken: The resin reaches the intestine unchanged (not absorbed) and binds bile acids secreted to digest the last meal.
- Bile acids leave in stool: Bound, they are not reabsorbed in the ileum — the enterohepatic circulation loses its cargo.
- Liver compensates: Sensing the loss, the liver converts cholesterol into new bile acids and up-regulates LDL receptors; LDL falls over weeks, though triglycerides may drift upward.
- Timing matters: Other medications taken too close in time may be bound and lost, so dosing is separated per manufacturer and prescriber guidance.
Common Confusions
| Common Confusion | Correct Understanding |
|---|---|
| "Sequestrants lower LDL by blocking dietary cholesterol" | They bind bile acids, forcing the liver to consume cholesterol — a different mechanism from blocking dietary absorption (Topic 4) |
| "All lipid drugs lower LDL the most" | Fibrates lower triglycerides most; niacin raises HDL most; LDL is the receptor- and intestine-based drugs' specialty |
| "The niacin flush is an allergic reaction" | It is prostaglandin-mediated vasodilation — expected, generally harmless |
| "Gemfibrozil and fenofibrate are interchangeable" | Same class, different interaction profiles (notably with statins); a prescriber decision |
| "Taking a sequestrant with other pills is fine" | It can bind other drugs and fat-soluble vitamins; timing separation is essential |
| "Fibrates are the answer for high LDL" | Fibrates mainly target triglycerides; LDL-dominant problems need receptor- and intestine-based strategies |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your liver makes a soap called bile to digest fat, and it normally recycles that soap. Bile acid sequestrants are like a sponge in your intestine that soaks up the soap, so your liver has to make new soap — using up cholesterol to do it, which lowers blood cholesterol. Fibrates are a speed-up button for the machines that burn fat in your blood, so triglycerides go down. Niacin is a vitamin that, at high doses, tells your liver to ship out less fat — but it can make your face feel hot and tingly, which is normal.
Worked example
A person with very high triglycerides and a history of pancreatitis starts a fibrate; a person with elevated LDL who cannot tolerate statins starts a bile acid sequestrant. To the first: "This drug speeds up the machinery that clears fat from your blood — triglycerides should come down; if you develop muscle pain or weakness, tell us right away." To the second: "This resin grabs bile in your gut so your liver uses cholesterol to make more — expect it to work slowly; take your other medicines at the time your pharmacist advises, and let us know if constipation is a problem."
Key takeaways
- Sequestrants bind bile acids → liver makes new ones from cholesterol → LDL receptors up-regulate → LDL falls; triglycerides may rise.
- Sequestrant signature issues: constipation and binding of other drugs/fat-soluble vitamins — separate other medications by the recommended interval.
- Fibrates activate PPARα → more lipoprotein lipase → large triglyceride falls and higher HDL; the class for very high triglycerides.
- Fibrate caution: muscle risk with statins (profiles differ between agents); also gallstones.
- Niacin raises HDL most among lipid drugs; the famous side effect is flushing — expected, not an allergy (but hyperglycemia, hyperuricemia, and hepatotoxicity are cautions).
- Phenotype logic: LDL problem → receptor/intestinal strategies; triglyceride problem → fibrates; low HDL → lifestyle first.
- Doses, combinations, monitoring, and drug-separation intervals all come from current guidelines, the formulary, and prescriber orders — verify, never guess.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
Explain the mechanism by which bile acid sequestrants lower LDL.
Show answer
Sequestrants bind bile acids in the intestine so they are excreted instead of reabsorbed; the liver consumes cholesterol making replacements and up-regulates LDL receptors, lowering plasma LDL.
What are the two signature cautions for bile acid sequestrants?
Show answer
Gastrointestinal effects (especially constipation) and binding of other drugs/fat-soluble vitamins — other medications must be separated by the recommended time interval.
What is the molecular target of fibrates, and which lipid fraction do they lower most?
Show answer
PPARα, which increases lipoprotein lipase activity; triglycerides are lowered most, with HDL also rising.
Why is flushing a known niacin effect, and why is teaching about it important?
Show answer
Niacin triggers prostaglandin-mediated vasodilation at lipid doses; patients not warned may stop the drug or mistake it for an allergy, so pre-teaching is essential.
Which two classes carry a muscle-safety concern when combined, and what should the nurse reinforce?
Show answer
Fibrates and statins — both can contribute to muscle toxicity; nurses reinforce prompt reporting of muscle pain, especially during combination therapy.
How does "lipid phenotype" guide drug selection?
Show answer
LDL-dominant patterns point to receptor- and intestine-based strategies; triglyceride-dominant patterns to fibrates; low HDL mainly to lifestyle — all individualized by the prescriber per current guidelines.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Bile acid sequestrant
- Non-absorbed resin that binds bile acids in the intestine so they leave in stool
- Enterohepatic circulation
- Recycling loop returning most bile acids from intestine to liver
- PPARα
- Nuclear receptor activating genes for fat-burning proteins like lipoprotein lipase
- Lipoprotein lipase
- Enzyme releasing fatty acids from triglyceride-rich particles
- Fibrate
- PPARα agonist drug class (e.g., gemfibrozil, fenofibrate)
- Niacin flush
- Warmth, redness, itching from prostaglandin-mediated vasodilation
- DGAT2
- Liver enzyme that assembles triglycerides
- Hyperuricemia
- Elevated uric acid in the blood
- Myopathy
- Muscle damage with elevated creatine kinase
- Fat-soluble vitamins
- Vitamins A, D, E, K absorbed with dietary fat
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.